| 0 |
LENTICULAR INJURY |
2 |
0.1176 |
| 1 |
PRIMARY STABBING HEADACHE |
5 |
0.0704 |
| 2 |
ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST |
1 |
0.0588 |
| 3 |
DIFFUSE UVEAL MELANOCYTIC PROLIFERATION |
1 |
0.0526 |
| 4 |
FIBRIN ABNORMAL |
1 |
0.0500 |
| 5 |
HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS |
3 |
0.0411 |
| 6 |
AQUEOUS FIBRIN |
2 |
0.0392 |
| 7 |
CORNEAL INFILTRATES |
12 |
0.0382 |
| 8 |
PUPILLARY BLOCK |
1 |
0.0312 |
| 9 |
EYE INFECTION INTRAOCULAR |
2 |
0.0256 |
| 10 |
CORNEAL IRRITATION |
2 |
0.0250 |
| 11 |
KERATITIS VIRAL |
1 |
0.0244 |
| 12 |
ANTERIOR CHAMBER FIBRIN |
3 |
0.0233 |
| 13 |
IRIS DISCOLOURATION |
1 |
0.0217 |
| 14 |
INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION |
1 |
0.0208 |
| 15 |
NEUROTROPHIC KERATOPATHY |
1 |
0.0185 |
| 16 |
HYPOPYON |
15 |
0.0181 |
| 17 |
PRODUCT GEL FORMATION |
2 |
0.0164 |
| 18 |
INFECTIVE SCLERITIS |
1 |
0.0111 |
| 19 |
VOCAL CORD CYST |
1 |
0.0102 |
| 20 |
FUNDOSCOPY ABNORMAL |
1 |
0.0096 |
| 21 |
VOGT-KOYANAGI-HARADA DISEASE |
2 |
0.0091 |
| 22 |
THERMAL BURNS OF EYE |
2 |
0.0088 |
| 23 |
PRECANCEROUS LESION OF DIGESTIVE TRACT |
1 |
0.0088 |
| 24 |
CORNEAL EPITHELIUM DEFECT |
5 |
0.0086 |
| 25 |
PERSISTENT CORNEAL EPITHELIAL DEFECT |
1 |
0.0085 |
| 26 |
DACRYOCANALICULITIS |
1 |
0.0085 |
| 27 |
DYSCHROMATOPSIA |
7 |
0.0084 |
| 28 |
BILIRUBIN URINE PRESENT |
1 |
0.0084 |
| 29 |
ANTERIOR CHAMBER CELL |
6 |
0.0084 |
| 30 |
ATROPHY OF GLOBE |
1 |
0.0078 |
| 31 |
PRODUCT DROPPER ISSUE |
6 |
0.0076 |
| 32 |
CORNEAL OEDEMA |
17 |
0.0076 |
| 33 |
TOXIC ANTERIOR SEGMENT SYNDROME |
8 |
0.0073 |
| 34 |
INCISION SITE OEDEMA |
1 |
0.0072 |
| 35 |
DERMATOCHALASIS |
1 |
0.0068 |
| 36 |
PUNCTATE KERATITIS |
6 |
0.0065 |
| 37 |
VACCINATION SITE SWELLING |
1 |
0.0058 |
| 38 |
TONGUE FUNGAL INFECTION |
1 |
0.0058 |
| 39 |
OPHTHALMOLOGICAL EXAMINATION ABNORMAL |
1 |
0.0056 |
| 40 |
SYPHILIS |
4 |
0.0055 |
| 41 |
EXCESSIVE EYE BLINKING |
8 |
0.0054 |
| 42 |
PERSEVERATION |
1 |
0.0054 |
| 43 |
SMOOTH MUSCLE ANTIBODY POSITIVE |
1 |
0.0053 |
| 44 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 45 |
CORNEAL DISORDER |
11 |
0.0050 |
| 46 |
RETINAL ANEURYSM |
1 |
0.0050 |
| 47 |
DYSMETRIA |
3 |
0.0050 |
| 48 |
KERATITIS FUNGAL |
1 |
0.0048 |
| 49 |
CORNEAL INFECTION |
1 |
0.0046 |
| 50 |
LASER THERAPY |
1 |
0.0044 |
| 51 |
CORNEAL OPACITY |
6 |
0.0044 |
| 52 |
ANTERIOR CHAMBER FLARE |
1 |
0.0043 |
| 53 |
CYSTOID MACULAR OEDEMA |
8 |
0.0042 |
| 54 |
CORNEAL SCAR |
2 |
0.0040 |
| 55 |
INFECTIVE TENOSYNOVITIS |
1 |
0.0040 |
| 56 |
CORNEAL THINNING |
1 |
0.0039 |
| 57 |
ENDOPHTHALMITIS |
23 |
0.0038 |
| 58 |
METAMORPHOPSIA |
7 |
0.0038 |
| 59 |
BACTERIAL ENDOPHTHALMITIS |
1 |
0.0038 |
| 60 |
OCULAR TOXICITY |
4 |
0.0036 |
| 61 |
PRODUCT CLOSURE ISSUE |
2 |
0.0036 |
| 62 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
0.0036 |
| 63 |
CARBUNCLE |
1 |
0.0035 |
| 64 |
VOCAL CORD INFLAMMATION |
1 |
0.0034 |
| 65 |
ANTERIOR CHAMBER INFLAMMATION |
2 |
0.0034 |
| 66 |
SUPERIOR VENA CAVA SYNDROME |
2 |
0.0033 |
| 67 |
RESTRICTIVE CARDIOMYOPATHY |
1 |
0.0033 |
| 68 |
EYE ABSCESS |
1 |
0.0033 |
| 69 |
IMPAIRED FASTING GLUCOSE |
1 |
0.0033 |
| 70 |
PARAKERATOSIS |
1 |
0.0031 |
| 71 |
POST PROCEDURAL CONTUSION |
1 |
0.0030 |
| 72 |
ACANTHOSIS |
1 |
0.0030 |
| 73 |
CONJUNCTIVAL OEDEMA |
3 |
0.0029 |
| 74 |
EYE OEDEMA |
7 |
0.0029 |
| 75 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
1 |
0.0028 |
| 76 |
PRODUCT DOSE CONFUSION |
1 |
0.0028 |
| 77 |
PRODUCT DESIGN ISSUE |
2 |
0.0028 |
| 78 |
VITRITIS |
5 |
0.0027 |
| 79 |
ALTERNARIA INFECTION |
1 |
0.0027 |
| 80 |
HUMAN HERPESVIRUS 6 INFECTION |
5 |
0.0026 |
| 81 |
ACCELERATED HYPERTENSION |
1 |
0.0026 |
| 82 |
EYE INFECTION FUNGAL |
1 |
0.0026 |
| 83 |
POOR QUALITY PRODUCT ADMINISTERED |
27 |
0.0026 |
| 84 |
ULCERATIVE KERATITIS |
7 |
0.0026 |
| 85 |
PRODUCT CONTAINER ISSUE |
21 |
0.0024 |
| 86 |
PROCEDURAL HEADACHE |
1 |
0.0024 |
| 87 |
CORNEAL DYSTROPHY |
1 |
0.0024 |
| 88 |
CARDITIS |
1 |
0.0024 |
| 89 |
HYPOTONY OF EYE |
1 |
0.0024 |
| 90 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
13 |
0.0023 |
| 91 |
PRODUCT CONTAINER SEAL ISSUE |
4 |
0.0023 |
| 92 |
MACULAR HOLE |
3 |
0.0022 |
| 93 |
GALLBLADDER CHOLESTEROLOSIS |
1 |
0.0022 |
| 94 |
OPEN FRACTURE |
1 |
0.0021 |
| 95 |
LIQUID PRODUCT PHYSICAL ISSUE |
15 |
0.0021 |
| 96 |
INTRAOCULAR LENS IMPLANT |
1 |
0.0020 |
| 97 |
GLARE |
1 |
0.0019 |
| 98 |
INJURY CORNEAL |
1 |
0.0019 |
| 99 |
IRIS DISORDER |
1 |
0.0019 |
| 100 |
CORNEAL EROSION |
1 |
0.0019 |
| 101 |
BURSITIS INFECTIVE |
1 |
0.0018 |
| 102 |
PRESBYOPIA |
1 |
0.0018 |
| 103 |
BACTERIURIA |
1 |
0.0018 |
| 104 |
HALO VISION |
2 |
0.0018 |
| 105 |
TREATMENT FAILURE |
146 |
0.0018 |
| 106 |
URINARY TRACT INFECTION FUNGAL |
1 |
0.0017 |
| 107 |
EYE ULCER |
1 |
0.0017 |
| 108 |
MEDICAL DEVICE REMOVAL |
3 |
0.0017 |
| 109 |
CATATONIA |
9 |
0.0017 |
| 110 |
EYE BURNS |
1 |
0.0017 |
| 111 |
HYPOAESTHESIA EYE |
1 |
0.0017 |
| 112 |
SPONDYLOARTHROPATHY |
1 |
0.0017 |
| 113 |
NEUROPSYCHOLOGICAL SYMPTOMS |
1 |
0.0017 |
| 114 |
SACRAL PAIN |
1 |
0.0016 |
| 115 |
PRODUCT LEAKAGE |
9 |
0.0016 |
| 116 |
URINARY SEDIMENT PRESENT |
1 |
0.0016 |
| 117 |
MACULAR FIBROSIS |
1 |
0.0015 |
| 118 |
EYE INFLAMMATION |
14 |
0.0015 |
| 119 |
LICHEN SCLEROSUS |
1 |
0.0015 |
| 120 |
CORNEAL ABRASION |
2 |
0.0015 |
| 121 |
GRANULOMATOUS LIVER DISEASE |
1 |
0.0014 |
| 122 |
FOREIGN BODY SENSATION IN EYES |
9 |
0.0014 |
| 123 |
EYELID MARGIN CRUSTING |
4 |
0.0014 |
| 124 |
GASTROINTESTINAL SCARRING |
1 |
0.0014 |
| 125 |
ASTIGMATISM |
2 |
0.0013 |
| 126 |
RETINAL INJURY |
1 |
0.0013 |
| 127 |
CORNEAL TRANSPLANT |
1 |
0.0013 |
| 128 |
KERATOPATHY |
2 |
0.0013 |
| 129 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
2 |
0.0012 |
| 130 |
SCLERITIS |
2 |
0.0012 |
| 131 |
CHOROIDAL EFFUSION |
1 |
0.0012 |
| 132 |
PROCEDURAL NAUSEA |
1 |
0.0012 |
| 133 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 134 |
PROSTATE CANCER METASTATIC |
4 |
0.0012 |
| 135 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 136 |
SEROUS RETINAL DETACHMENT |
1 |
0.0012 |
| 137 |
NON-INFECTIOUS ENDOPHTHALMITIS |
1 |
0.0012 |
| 138 |
MYCOTIC ALLERGY |
1 |
0.0012 |
| 139 |
PRODUCT COLOUR ISSUE |
6 |
0.0012 |
| 140 |
CHOROIDAL NEOVASCULARISATION |
1 |
0.0012 |
| 141 |
RETINITIS |
2 |
0.0012 |
| 142 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 143 |
DRUG LEVEL FLUCTUATING |
1 |
0.0011 |
| 144 |
DETACHMENT OF RETINAL PIGMENT EPITHELIUM |
1 |
0.0011 |
| 145 |
VITREOUS FLOATERS |
11 |
0.0011 |
| 146 |
EYE PAIN |
63 |
0.0011 |
| 147 |
PRODUCT DELIVERY MECHANISM ISSUE |
6 |
0.0011 |
| 148 |
VISUAL FIELD DEFECT |
8 |
0.0011 |
| 149 |
SINUS NODE DYSFUNCTION |
2 |
0.0011 |
| 150 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 151 |
HYPERMETROPIA |
1 |
0.0011 |
| 152 |
RETINAL OEDEMA |
2 |
0.0010 |
| 153 |
FOREIGN BODY IN EYE |
1 |
0.0010 |
| 154 |
HEMIANOPIA |
1 |
0.0010 |
| 155 |
EYE IRRITATION |
58 |
0.0010 |
| 156 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 157 |
EYELID PAIN |
2 |
0.0010 |
| 158 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
1 |
0.0010 |
| 159 |
PRODUCT COATING ISSUE |
1 |
0.0010 |
| 160 |
BRAIN STEM INFARCTION |
1 |
0.0010 |
| 161 |
VITREOUS DETACHMENT |
2 |
0.0009 |
| 162 |
INSTILLATION SITE REACTION |
1 |
0.0009 |
| 163 |
MACULAR OEDEMA |
5 |
0.0009 |
| 164 |
SUBCLAVIAN VEIN THROMBOSIS |
1 |
0.0009 |
| 165 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 166 |
EPSTEIN-BARR VIRUS INFECTION |
5 |
0.0008 |
| 167 |
EYELID IRRITATION |
2 |
0.0008 |
| 168 |
INTRAOCULAR PRESSURE INCREASED |
10 |
0.0008 |
| 169 |
DRUG PRESCRIBING ERROR |
15 |
0.0008 |
| 170 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 171 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
2 |
0.0008 |
| 172 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
1 |
0.0008 |
| 173 |
SKIN WRINKLING |
2 |
0.0007 |
| 174 |
INCISIONAL HERNIA |
1 |
0.0007 |
| 175 |
OCULAR DISCOMFORT |
8 |
0.0007 |
| 176 |
GLUTEN SENSITIVITY |
1 |
0.0007 |
| 177 |
MUTISM |
1 |
0.0007 |
| 178 |
COCCYDYNIA |
1 |
0.0007 |
| 179 |
CATARACT OPERATION |
4 |
0.0007 |
| 180 |
SUPERINFECTION |
1 |
0.0007 |
| 181 |
REBOUND ACID HYPERSECRETION |
2 |
0.0007 |
| 182 |
KERATITIS |
2 |
0.0007 |
| 183 |
PRODUCT PHYSICAL ISSUE |
13 |
0.0006 |
| 184 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 185 |
IRIDOCYCLITIS |
2 |
0.0006 |
| 186 |
LACRIMATION INCREASED |
19 |
0.0006 |
| 187 |
OPTIC ATROPHY |
1 |
0.0006 |
| 188 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 189 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 190 |
RETINAL THICKENING |
1 |
0.0006 |
| 191 |
OCULAR HYPERAEMIA |
28 |
0.0006 |
| 192 |
RECALLED PRODUCT |
1 |
0.0006 |
| 193 |
PUPIL FIXED |
1 |
0.0006 |
| 194 |
PAPILLARY THYROID CANCER |
1 |
0.0006 |
| 195 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 196 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 197 |
HISTOPLASMOSIS |
1 |
0.0006 |
| 198 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 199 |
CONJUNCTIVAL HYPERAEMIA |
2 |
0.0006 |
| 200 |
EXTRA DOSE ADMINISTERED |
22 |
0.0005 |
| 201 |
DISORGANISED SPEECH |
1 |
0.0005 |
| 202 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 203 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 204 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 205 |
HYPERAEMIA |
1 |
0.0005 |
| 206 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 207 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 208 |
VOCAL CORD DISORDER |
1 |
0.0005 |
| 209 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
17 |
0.0005 |
| 210 |
EMPYEMA |
1 |
0.0005 |
| 211 |
BLEPHARITIS |
2 |
0.0005 |
| 212 |
SUDDEN HEARING LOSS |
1 |
0.0005 |
| 213 |
IMPAIRED HEALING |
16 |
0.0005 |
| 214 |
CHANGE OF BOWEL HABIT |
1 |
0.0005 |
| 215 |
SELF-MEDICATION |
2 |
0.0005 |
| 216 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 217 |
PHARYNGEAL ERYTHEMA |
1 |
0.0005 |
| 218 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 219 |
ABNORMAL SENSATION IN EYE |
2 |
0.0005 |
| 220 |
EXOPHTHALMOS |
1 |
0.0005 |
| 221 |
PARANOIA |
8 |
0.0005 |
| 222 |
PRODUCT DISPENSING ERROR |
10 |
0.0005 |
| 223 |
PHYSICAL DISABILITY |
2 |
0.0005 |
| 224 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 225 |
FAECES PALE |
1 |
0.0004 |
| 226 |
PRODUCT STORAGE ERROR |
39 |
0.0004 |
| 227 |
PRODUCT ADMINISTRATION ERROR |
9 |
0.0004 |
| 228 |
PRODUCT USE COMPLAINT |
7 |
0.0004 |
| 229 |
HEPATOCELLULAR DAMAGE |
1 |
0.0004 |
| 230 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 231 |
UVEITIS |
6 |
0.0004 |
| 232 |
DERMATITIS CONTACT |
5 |
0.0004 |
| 233 |
RETINAL DETACHMENT |
4 |
0.0004 |
| 234 |
EYE OPERATION |
2 |
0.0004 |
| 235 |
HAEMANGIOMA |
1 |
0.0004 |
| 236 |
NEPHROGENIC ANAEMIA |
2 |
0.0004 |
| 237 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
11 |
0.0004 |
| 238 |
SKIN ABRASION |
2 |
0.0004 |
| 239 |
WRONG DOSE |
1 |
0.0004 |
| 240 |
GLOMERULONEPHRITIS |
1 |
0.0004 |
| 241 |
INSTILLATION SITE PAIN |
1 |
0.0004 |
| 242 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 243 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 244 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 245 |
RETINAL DISORDER |
1 |
0.0004 |
| 246 |
PHOTOPHOBIA |
7 |
0.0004 |
| 247 |
ENCEPHALOPATHY |
9 |
0.0004 |
| 248 |
CLONUS |
1 |
0.0004 |
| 249 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 250 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
0.0004 |
| 251 |
RHINALGIA |
1 |
0.0004 |
| 252 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 253 |
REBOUND EFFECT |
4 |
0.0004 |
| 254 |
CATARACT |
21 |
0.0004 |
| 255 |
PRODUCT DOSE OMISSION |
23 |
0.0004 |
| 256 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 257 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 258 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 259 |
HAEMOTHORAX |
1 |
0.0003 |
| 260 |
MADAROSIS |
4 |
0.0003 |
| 261 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 262 |
HALLUCINATION, VISUAL |
7 |
0.0003 |
| 263 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 264 |
IRITIS |
1 |
0.0003 |
| 265 |
DYSCHEZIA |
1 |
0.0003 |
| 266 |
MYDRIASIS |
4 |
0.0003 |
| 267 |
POOR QUALITY DRUG ADMINISTERED |
2 |
0.0003 |
| 268 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 269 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 270 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 271 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 272 |
ANXIETY DISORDER |
1 |
0.0003 |
| 273 |
EYE SWELLING |
11 |
0.0003 |
| 274 |
ECCHYMOSIS |
2 |
0.0003 |
| 275 |
POOR VENOUS ACCESS |
3 |
0.0003 |
| 276 |
EYE DISCHARGE |
3 |
0.0003 |
| 277 |
MACULOPATHY |
1 |
0.0003 |
| 278 |
GLOSSITIS |
1 |
0.0003 |
| 279 |
RETINOPATHY |
1 |
0.0003 |
| 280 |
EYE INFECTION |
3 |
0.0003 |
| 281 |
TOXIC EPIDERMAL NECROLYSIS |
4 |
0.0003 |
| 282 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 283 |
INSURANCE ISSUE |
4 |
0.0003 |
| 284 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 285 |
THYROID MASS |
1 |
0.0003 |
| 286 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 287 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 288 |
ATAXIA |
3 |
0.0003 |
| 289 |
OBSTRUCTION |
1 |
0.0003 |
| 290 |
TRIGGER FINGER |
1 |
0.0002 |
| 291 |
EYE PRURITUS |
8 |
0.0002 |
| 292 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 293 |
PRODUCT DOSE OMISSION ISSUE |
69 |
0.0002 |
| 294 |
VISUAL IMPAIRMENT |
29 |
0.0002 |
| 295 |
HORDEOLUM |
1 |
0.0002 |
| 296 |
DEVICE DEFECTIVE |
4 |
0.0002 |
| 297 |
CHAPPED LIPS |
1 |
0.0002 |
| 298 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 299 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 300 |
PAPILLOEDEMA |
1 |
0.0002 |
| 301 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 302 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 303 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
| 304 |
RECALLED PRODUCT ADMINISTERED |
2 |
0.0002 |
| 305 |
GLAUCOMA |
4 |
0.0002 |
| 306 |
PRODUCT QUALITY ISSUE |
28 |
0.0002 |
| 307 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 308 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 309 |
DRY EYE |
10 |
0.0002 |
| 310 |
VEIN DISORDER |
1 |
0.0002 |
| 311 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 312 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 313 |
VISION BLURRED |
27 |
0.0002 |
| 314 |
DRUG DELIVERY SYSTEM MALFUNCTION |
1 |
0.0002 |
| 315 |
INITIAL INSOMNIA |
2 |
0.0002 |
| 316 |
EAR DISCOMFORT |
2 |
0.0002 |
| 317 |
VARICOSE VEIN |
1 |
0.0002 |
| 318 |
PRODUCT USE ISSUE |
36 |
0.0002 |
| 319 |
POLYARTHRITIS |
1 |
0.0002 |
| 320 |
SCIATICA |
3 |
0.0002 |
| 321 |
PHARYNGOLARYNGEAL PAIN |
1 |
0.0002 |
| 322 |
BODY HEIGHT DECREASED |
2 |
0.0002 |
| 323 |
OVERWEIGHT |
1 |
0.0002 |
| 324 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 325 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 326 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 327 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 328 |
TIC |
1 |
0.0002 |
| 329 |
HYPERKERATOSIS |
1 |
0.0002 |
| 330 |
PROSTATIC DISORDER |
1 |
0.0002 |
| 331 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 332 |
CHROMATURIA |
4 |
0.0002 |
| 333 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 334 |
SCAR |
3 |
0.0002 |
| 335 |
SKIN ATROPHY |
1 |
0.0002 |
| 336 |
EYELID OEDEMA |
2 |
0.0002 |
| 337 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 338 |
PLEURISY |
1 |
0.0002 |
| 339 |
MACULAR DEGENERATION |
2 |
0.0002 |
| 340 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 341 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 342 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 343 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 344 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 345 |
SWELLING OF EYELID |
1 |
0.0002 |
| 346 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 347 |
EAR PAIN |
3 |
0.0002 |
| 348 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 349 |
RESPIRATORY TRACT INFECTION |
4 |
0.0002 |
| 350 |
INCORRECT PRODUCT STORAGE |
2 |
0.0002 |
| 351 |
WALKING AID USER |
1 |
0.0002 |
| 352 |
SKIN MASS |
1 |
0.0001 |
| 353 |
MENINGITIS |
1 |
0.0001 |
| 354 |
TERMINAL STATE |
1 |
0.0001 |
| 355 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 356 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 357 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 358 |
HALLUCINATION |
11 |
0.0001 |
| 359 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 360 |
PAPULE |
1 |
0.0001 |
| 361 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 362 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 363 |
FAECES SOFT |
1 |
0.0001 |
| 364 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 365 |
PSYCHOTIC DISORDER |
4 |
0.0001 |
| 366 |
LIPASE INCREASED |
1 |
0.0001 |
| 367 |
SHOCK |
3 |
0.0001 |
| 368 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 369 |
FOOD ALLERGY |
1 |
0.0001 |
| 370 |
CONCUSSION |
1 |
0.0001 |
| 371 |
APHTHOUS ULCER |
1 |
0.0001 |
| 372 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 373 |
FURUNCLE |
1 |
0.0001 |
| 374 |
BLOOD DISORDER |
1 |
0.0001 |
| 375 |
UTERINE CANCER |
1 |
0.0001 |
| 376 |
SENSORY LOSS |
1 |
0.0001 |
| 377 |
STENT PLACEMENT |
1 |
0.0001 |
| 378 |
BLINDNESS |
5 |
0.0001 |
| 379 |
EYE DISORDER |
4 |
0.0001 |
| 380 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 381 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 382 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 383 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 384 |
SKIN ULCER |
3 |
0.0001 |
| 385 |
NO ADVERSE EVENT |
21 |
0.0001 |
| 386 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 387 |
CARDIAC MURMUR |
1 |
0.0001 |
| 388 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 389 |
BRADYCARDIA |
6 |
0.0001 |
| 390 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 391 |
FACIAL PAIN |
1 |
0.0001 |
| 392 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 393 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 394 |
DRUG DOSE OMISSION |
18 |
0.0001 |
| 395 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 396 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
| 397 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 398 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 399 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 400 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 401 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 402 |
HERNIA |
2 |
0.0001 |
| 403 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 404 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 405 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 406 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 407 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 408 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 409 |
COMPLICATION OF DEVICE INSERTION |
2 |
0.0001 |
| 410 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 411 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 412 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 413 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 414 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 415 |
ECZEMA |
5 |
0.0001 |
| 416 |
TRANSFUSION |
1 |
0.0001 |
| 417 |
JOINT DISLOCATION |
1 |
0.0001 |
| 418 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 419 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 420 |
BALANCE DISORDER |
8 |
0.0001 |
| 421 |
OEDEMA |
5 |
0.0001 |
| 422 |
SKIN LACERATION |
1 |
0.0001 |
| 423 |
BACK INJURY |
1 |
0.0001 |
| 424 |
OESOPHAGITIS |
1 |
0.0001 |
| 425 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 426 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 427 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 428 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 429 |
HEPATOTOXICITY |
2 |
0.0001 |
| 430 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 431 |
SCAB |
1 |
0.0001 |
| 432 |
OFF LABEL USE |
75 |
0.0001 |
| 433 |
SPLENOMEGALY |
1 |
0.0001 |
| 434 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 435 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 436 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
4 |
0.0001 |
| 437 |
INCORRECT DOSE ADMINISTERED |
19 |
0.0001 |
| 438 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
15 |
0.0001 |
| 439 |
LOCALISED INFECTION |
2 |
0.0001 |
| 440 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 441 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 442 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 443 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 444 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 445 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 446 |
AGEUSIA |
2 |
0.0001 |
| 447 |
DYSARTHRIA |
3 |
0.0001 |
| 448 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 449 |
ILLNESS |
8 |
0.0001 |
| 450 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 451 |
ANOREXIA |
1 |
0.0001 |
| 452 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 453 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 454 |
DIPLOPIA |
2 |
0.0001 |
| 455 |
BLOOD CREATININE INCREASED |
5 |
0.0001 |
| 456 |
DEAFNESS |
2 |
0.0001 |
| 457 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 458 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 459 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 460 |
DRUG INTERACTION |
12 |
0.0001 |
| 461 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 462 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 463 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 464 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 465 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 466 |
DEVICE DELIVERY SYSTEM ISSUE |
2 |
0.0001 |
| 467 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 468 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 469 |
MASS |
1 |
0.0001 |
| 470 |
BURNING SENSATION |
5 |
0.0001 |
| 471 |
BLISTER |
4 |
0.0001 |
| 472 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 473 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 474 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 475 |
FLATULENCE |
4 |
0.0001 |
| 476 |
HYPERHIDROSIS |
9 |
0.0001 |
| 477 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 478 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 479 |
GASTROENTERITIS |
1 |
0.0001 |
| 480 |
UNDERDOSE |
5 |
0.0001 |
| 481 |
SURGERY |
4 |
0.0001 |
| 482 |
ACCIDENTAL EXPOSURE TO PRODUCT |
7 |
0.0001 |
| 483 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 484 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 485 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 486 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 487 |
OSTEOPENIA |
1 |
0.0001 |
| 488 |
DISCOMFORT |
4 |
0.0001 |
| 489 |
TINNITUS |
3 |
0.0001 |
| 490 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 491 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 492 |
THYROID DISORDER |
1 |
0.0001 |
| 493 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 494 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 495 |
BRAIN FOG |
1 |
0.0001 |
| 496 |
HEAD INJURY |
2 |
0.0001 |
| 497 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 498 |
ABSCESS |
1 |
0.0001 |
| 499 |
BLOOD GLUCOSE DECREASED |
3 |
0.0001 |
| 500 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 501 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 502 |
PRODUCT USE IN UNAPPROVED INDICATION |
15 |
0.0001 |
| 503 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 504 |
VIRAL INFECTION |
2 |
0.0001 |
| 505 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 506 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 507 |
THERAPY CESSATION |
3 |
0.0001 |
| 508 |
INFLAMMATION |
3 |
0.0001 |
| 509 |
LOCAL SWELLING |
1 |
0.0001 |
| 510 |
AMENORRHOEA |
1 |
0.0001 |
| 511 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 512 |
DRUG ERUPTION |
1 |
0.0001 |
| 513 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 514 |
CONDITION AGGRAVATED |
17 |
0.0001 |
| 515 |
OSTEOMYELITIS |
1 |
0.0001 |
| 516 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 517 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 518 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 519 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
11 |
0.0001 |
| 520 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 521 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 522 |
NECK PAIN |
3 |
0.0001 |
| 523 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 524 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 525 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 526 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 527 |
PROTEINURIA |
1 |
0.0001 |
| 528 |
INCREASED APPETITE |
1 |
0.0001 |
| 529 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 530 |
ERUCTATION |
1 |
0.0001 |
| 531 |
DYSPHONIA |
3 |
0.0001 |
| 532 |
DISABILITY |
1 |
0.0001 |
| 533 |
SINUS DISORDER |
1 |
0.0001 |
| 534 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 535 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 536 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 537 |
SYNCOPE |
5 |
0.0000 |
| 538 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 539 |
FEEDING DISORDER |
1 |
0.0000 |
| 540 |
TASTE DISORDER |
1 |
0.0000 |
| 541 |
SINUSITIS |
5 |
0.0000 |
| 542 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 543 |
OSTEOPOROSIS |
2 |
0.0000 |
| 544 |
DRUG INEFFECTIVE |
64 |
0.0000 |
| 545 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 546 |
DERMATITIS |
1 |
0.0000 |
| 547 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 548 |
MOUTH ULCERATION |
1 |
0.0000 |
| 549 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 550 |
JOINT INJURY |
1 |
0.0000 |
| 551 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 552 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 553 |
HYPOACUSIS |
2 |
0.0000 |
| 554 |
SKIN CANCER |
1 |
0.0000 |
| 555 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 556 |
SWELLING FACE |
3 |
0.0000 |
| 557 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 558 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 559 |
ANGIOEDEMA |
2 |
0.0000 |
| 560 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 561 |
ORAL PAIN |
1 |
0.0000 |
| 562 |
SNEEZING |
1 |
0.0000 |
| 563 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 564 |
ARRHYTHMIA |
2 |
0.0000 |
| 565 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 566 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 567 |
HEADACHE |
26 |
0.0000 |
| 568 |
RASH |
18 |
0.0000 |
| 569 |
FIBROMYALGIA |
1 |
0.0000 |
| 570 |
PRESYNCOPE |
1 |
0.0000 |
| 571 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 572 |
LUNG DISORDER |
2 |
0.0000 |
| 573 |
COVID-19 |
7 |
0.0000 |
| 574 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 575 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 576 |
DIABETES MELLITUS |
3 |
0.0000 |
| 577 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 578 |
HYPOPHAGIA |
1 |
0.0000 |
| 579 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 580 |
ABDOMINAL PAIN UPPER |
8 |
0.0000 |
| 581 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 582 |
SPEECH DISORDER |
2 |
0.0000 |
| 583 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 584 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 585 |
MUSCLE SPASMS |
7 |
0.0000 |
| 586 |
DIZZINESS |
19 |
0.0000 |
| 587 |
ANHEDONIA |
1 |
0.0000 |
| 588 |
GASTRITIS |
1 |
0.0000 |
| 589 |
NASOPHARYNGITIS |
7 |
0.0000 |
| 590 |
DEPRESSED MOOD |
2 |
0.0000 |
| 591 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 592 |
DEHYDRATION |
5 |
0.0000 |
| 593 |
DRY SKIN |
5 |
0.0000 |
| 594 |
THROMBOSIS |
3 |
0.0000 |
| 595 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 596 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 597 |
PALLOR |
1 |
0.0000 |
| 598 |
CONSTIPATION |
8 |
0.0000 |
| 599 |
MOOD ALTERED |
1 |
0.0000 |
| 600 |
SKIN LESION |
1 |
0.0000 |
| 601 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 602 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 603 |
MEDICATION ERROR |
2 |
0.0000 |
| 604 |
INFLUENZA |
4 |
0.0000 |
| 605 |
SEPSIS |
4 |
0.0000 |
| 606 |
COUGH |
10 |
0.0000 |
| 607 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 608 |
ANGINA PECTORIS |
1 |
0.0000 |
| 609 |
HYPERSOMNIA |
1 |
0.0000 |
| 610 |
FATIGUE |
27 |
0.0000 |
| 611 |
BACK PAIN |
8 |
0.0000 |
| 612 |
NEEDLE ISSUE |
1 |
0.0000 |
| 613 |
DYSSTASIA |
1 |
0.0000 |
| 614 |
PALPITATIONS |
4 |
0.0000 |
| 615 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 616 |
RENAL INJURY |
1 |
0.0000 |
| 617 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 618 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 619 |
FEELING ABNORMAL |
8 |
0.0000 |
| 620 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 621 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 622 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 623 |
CARDIAC DISORDER |
3 |
0.0000 |
| 624 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 625 |
ASTHENIA |
12 |
0.0000 |
| 626 |
DYSPHAGIA |
3 |
0.0000 |
| 627 |
CYSTITIS |
1 |
0.0000 |
| 628 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 629 |
ARTHRALGIA |
13 |
0.0000 |
| 630 |
PRURITUS |
12 |
0.0000 |
| 631 |
NIGHT SWEATS |
1 |
0.0000 |
| 632 |
RHINORRHOEA |
2 |
0.0000 |
| 633 |
PAIN |
19 |
0.0000 |
| 634 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 635 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 636 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 637 |
FUNGAL INFECTION |
1 |
0.0000 |
| 638 |
URINARY RETENTION |
1 |
0.0000 |
| 639 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 640 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 641 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 642 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 643 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 644 |
NIGHTMARE |
1 |
0.0000 |
| 645 |
DELIRIUM |
1 |
0.0000 |
| 646 |
DEVICE USE ERROR |
1 |
0.0000 |
| 647 |
HYPERKALAEMIA |
1 |
0.0000 |
| 648 |
INJURY |
2 |
0.0000 |
| 649 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 650 |
MOBILITY DECREASED |
2 |
0.0000 |
| 651 |
INFECTION |
4 |
0.0000 |
| 652 |
CRYING |
1 |
0.0000 |
| 653 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 654 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 655 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 656 |
AGITATION |
2 |
0.0000 |
| 657 |
DYSURIA |
1 |
0.0000 |
| 658 |
FALL |
9 |
0.0000 |
| 659 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 660 |
EPISTAXIS |
2 |
0.0000 |
| 661 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 662 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 663 |
COLITIS |
1 |
0.0000 |
| 664 |
ACNE |
2 |
0.0000 |
| 665 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 666 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 667 |
SEIZURE |
3 |
0.0000 |
| 668 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 669 |
ARTHRITIS |
2 |
0.0000 |
| 670 |
NAUSEA |
20 |
0.0000 |
| 671 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 672 |
JOINT SWELLING |
3 |
0.0000 |
| 673 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 674 |
DRY MOUTH |
2 |
0.0000 |
| 675 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 676 |
ERYTHEMA |
5 |
0.0000 |
| 677 |
POLLAKIURIA |
1 |
0.0000 |
| 678 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 679 |
URTICARIA |
4 |
0.0000 |
| 680 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 681 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 682 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 683 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 684 |
RENAL FAILURE |
3 |
0.0000 |
| 685 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 686 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 687 |
DEVICE ISSUE |
2 |
0.0000 |
| 688 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 689 |
THROAT IRRITATION |
1 |
0.0000 |
| 690 |
DEPRESSION |
5 |
0.0000 |
| 691 |
SKIN IRRITATION |
1 |
0.0000 |
| 692 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 693 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 694 |
HYPOKALAEMIA |
1 |
0.0000 |
| 695 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 696 |
CHEST PAIN |
4 |
0.0000 |
| 697 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 698 |
RENAL DISORDER |
1 |
0.0000 |
| 699 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 700 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 701 |
CONTUSION |
2 |
0.0000 |
| 702 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 703 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 704 |
MALAISE |
9 |
0.0000 |
| 705 |
DYSPEPSIA |
2 |
0.0000 |
| 706 |
HEART RATE INCREASED |
2 |
0.0000 |
| 707 |
LEUKOPENIA |
1 |
0.0000 |
| 708 |
CELLULITIS |
1 |
0.0000 |
| 709 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 710 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 711 |
DYSPNOEA |
11 |
0.0000 |
| 712 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 713 |
NERVOUSNESS |
1 |
0.0000 |
| 714 |
PANCREATITIS |
1 |
0.0000 |
| 715 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 716 |
INSOMNIA |
5 |
0.0000 |
| 717 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 718 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 719 |
ARTHROPATHY |
1 |
0.0000 |
| 720 |
WEIGHT DECREASED |
5 |
0.0000 |
| 721 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 722 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 723 |
MYALGIA |
3 |
0.0000 |
| 724 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 725 |
HERPES ZOSTER |
1 |
0.0000 |
| 726 |
DECREASED APPETITE |
4 |
0.0000 |
| 727 |
BONE PAIN |
1 |
0.0000 |
| 728 |
CHILLS |
2 |
0.0000 |
| 729 |
NASAL CONGESTION |
1 |
0.0000 |
| 730 |
BLADDER CANCER |
1 |
0.0000 |
| 731 |
WHEEZING |
1 |
0.0000 |
| 732 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 733 |
STOMATITIS |
1 |
0.0000 |
| 734 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 735 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 736 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 737 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 738 |
ANAEMIA |
3 |
0.0000 |
| 739 |
PNEUMONIA |
5 |
0.0000 |
| 740 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 741 |
PSORIASIS |
2 |
0.0000 |
| 742 |
HYPOTENSION |
3 |
0.0000 |
| 743 |
VOMITING |
7 |
0.0000 |
| 744 |
SLEEP DISORDER |
1 |
0.0000 |
| 745 |
HYPERTENSION |
3 |
0.0000 |
| 746 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 747 |
OVERDOSE |
3 |
0.0000 |
| 748 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 749 |
BRONCHITIS |
1 |
0.0000 |
| 750 |
DYSGEUSIA |
1 |
0.0000 |
| 751 |
HYPOAESTHESIA |
2 |
0.0000 |
| 752 |
HOT FLUSH |
1 |
0.0000 |
| 753 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 754 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 755 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 756 |
CARDIAC FAILURE |
1 |
0.0000 |
| 757 |
PROSTATE CANCER |
1 |
0.0000 |
| 758 |
DIARRHOEA |
8 |
0.0000 |
| 759 |
TREMOR |
2 |
0.0000 |
| 760 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 761 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 762 |
BREAST CANCER |
1 |
0.0000 |
| 763 |
SWELLING |
1 |
0.0000 |
| 764 |
ANXIETY |
3 |
0.0000 |
| 765 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 766 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 767 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 768 |
ALOPECIA |
2 |
0.0000 |
| 769 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 770 |
HAEMORRHAGE |
1 |
0.0000 |
| 771 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 772 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 773 |
WEIGHT INCREASED |
2 |
0.0000 |
| 774 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 775 |
HOSPITALISATION |
1 |
0.0000 |
| 776 |
PARAESTHESIA |
1 |
0.0000 |
| 777 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 778 |
PYREXIA |
2 |
0.0000 |
| 779 |
SOMNOLENCE |
1 |
0.0000 |
| 780 |
DEATH |
4 |
0.0000 |